Want to join the conversation?
$ORLY 2Q15 Q&A: Gutman of Morgan Stanley asked about GM, ex LIFO of 80 BPs. Tom commented that yes, the LIFO headwind higher than expected drove the slightly below percentage. ORLY has been consistent in the 51.8-52.2% range quarter-after-quarter and have accomplished that, but the additional $5MM headwind over last year was more than expected.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.